Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes

J S Westerdahl¹, K B Nusbaum², C G Chung^{3

4}, B H Kaffenberger³, A G Ortega-Loayza⁵

Affiliations

¹ School of Medicine, University of Utah, Salt Lake City, UT, USA.
² College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
³ Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
⁴ Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
⁵ Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

Free article

J S Westerdahl et al. J Dermatolog Treat. 2022 Jun.

Free article

. 2022 Jun;33(4):2386-2390.

doi: 10.1080/09546634.2021.1937475. Epub 2021 Jun 14.

J S Westerdahl¹, K B Nusbaum², C G Chung^{3

4}, B H Kaffenberger³, A G Ortega-Loayza⁵

¹ School of Medicine, University of Utah, Salt Lake City, UT, USA.
² College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
³ Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
⁴ Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
⁵ Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

No abstract available

Publication types